16 research outputs found
Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles
Introduction. Coasting is the most commonly used strategy in prevention of severe OHSS. Serum FSH levels measurements during coasting may aid in optimizing the duration of coasting. Objective(s). To study live birth rates (LBRs), clinical pregnancy rates (CPRs), and optimal duration of coasting based on serum FSH levels on the hCG day. Materials and Methods. It is a retrospective study performed between 2005 and 2008 at Barts and The London Centre for Reproductive Medicine, NHS Trust, London, UK, on 349-coasted women undergoing controlled ovarian stimulation (COS) for IVF ± ICSI. The serum FSH level measurements on the hCG day during coasting programme were analysed to predict the LBR and CPR. Result(s). LBR and CPR were significantly higher when the FSH levels on the hCG day were >2.5âIU/L (LBR: 32.5%, P = 0.045 and CPR: 36.9%, P = 0.027) compared to FSH <2.5âIU/L. The optimal FSH cut-off level for LBR and CPR is 5.6âIU/L on the hCG day. The optimal cutoff for coasting is 4 days. Conclusion(s). Coasting may be continued as long as either serum FSH level is > 2.5âIU/L on the hCG day without compromising the LBR and CPR or to maximum of 4 days
Clinical Study Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles
Introduction. Coasting is the most commonly used strategy in prevention of severe OHSS. Serum FSH levels measurements during coasting may aid in optimizing the duration of coasting. Objective(s). To study live birth rates (LBRs), clinical pregnancy rates (CPRs), and optimal duration of coasting based on serum FSH levels on the hCG day. Materials and Methods. It is a retrospective study performed between 2005 and 2008 at Barts and The London Centre for Reproductive Medicine, NHS Trust, London, UK, on 349-coasted women undergoing controlled ovarian stimulation (COS) for IVF ± ICSI. The serum FSH level measurements on the hCG day during coasting programme were analysed to predict the LBR and CPR. Result(s). LBR and CPR were significantly higher when the FSH levels on the hCG day were >2.5 IU/L (LBR: 32.5%, P = 0.045 and CPR: 36.9%, P = 0.027) compared to FSH <2.5 IU/L. The optimal FSH cut-off level for LBR and CPR is 5.6 IU/L on the hCG day. The optimal cutoff for coasting is 4 days. Conclusion(s). Coasting may be continued as long as either serum FSH level is > 2.5 IU/L on the hCG day without compromising the LBR and CPR or to maximum of 4 days
CASE REPORT - Successful pregnancy and delivery following IVF treatment in a patient with endometrial polyp diagnosed by saline infusion sonohysterography at oocyte retrieval
Background: There is lack of consensus regarding the management of
patients diagnosed with endometrial polyp in assisted reproductive
technology (ART) cycles. Saline infusion Sonohysterography (SIS) may
provide more precise identification of endometrial pathology without
need for hysteroscopy, cycle cancellation or cryopreservation of all
embryos. Case: A 38 year-old woman with endometrial polyp diagnosed by
saline infusion sonohysterography (SIS) during controlled ovarian
hyperstimulation (COH) which necessitated the intervention where
diagnosis was confirmed after oocyte retrieval. Several options were
discussed with patient who opted for fresh embryo transfer that
resulted in normal pregnancy and delivery. Conclusion: Normal pregnancy
and deliver can be achieved in the presence of an endometrial polyp
during IVF. Performing SIS near the time of embryo transfer did not
prevent implantation
Luteal phase support in assisted reproduction: United Kingdom survey
Objective: Probing practices of luteal phase support in assisted
reproductive technology (ART) centers in U.K. Materials and methods: A
question survey was conducted via the recognized centre by the HFEA
(Human Fertilization Embryology Authority) registry for year 2005.
Questions covered importance, optimal hormone for luteal support and
optimal route and length of progesterone and human chorionic
gonadotrophin (hCG) administration for women undergoing assisted
reproductive technologies. Main outcome measures: The main outcome
measures were importance, optimal hormone, and optimal route, dose,
length of progesterone, estrogen and hCG administration. Results: 82
centers licensed for in vitro fertilization / Donor insemination
(IVF/DI) acknowledge receiving the survey. Of those, 69 centers perform
in vitro fertilization / intra cytoplasmic sperm injection (IVF/ICSI).
60 (87%) centers replied. Luteal support was very important in 65% and
important in 31%. 97% used it in long down regulation protocol. The
routine use of luteal support following controlled ovarian
hyperstimulation (COH) with all stimulated cycles was 80.6%. HCG was
behind the progesterone in its use in this survey. Cyclogest
(progesterone pessaries) was the first choice of those selected as a
preference in 55%. 92% of IVF/ICSI centers that responded to the
questionnaire use cyclogest. The commonest dose used is 400 mg twice
daily (BD). The other leaders are intramuscular progesterone (42%), hCG
(38%), and vaginal progesterone gel (25%). The common practice is to
start luteal support from the day of oocyte collection (48%) and 48%
centers continue support until 12 weeks gestation. Conclusion:Luteal
phase support in ART is regarded as important by majority of specialist
centre. Cyclogest is the most widely used luteal phase support